List of largest biomedical companies by revenue

Last updated

The following is a list of independent pharmaceutical, biotechnology and medical companies listed on a stock exchange (as indicated) that have generated a revenue of at least US$10 billion, ranked by their revenue in the respective financial year.

Contents

It does not include biotechnology companies that are now owned by, or form a part of, larger pharmaceutical groups.

Ranking by revenue

The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa. Green cells indicate years where revenue increased compared to the preceding year. Red cells indicate those years where there has been a decrease.

RankChgCompanyCountryTraded on2023202220212020201920182017201620152014
1Increase2.svg 1 Johnson & Johnson Flag of the United States.svg  USA NYSE :  JNJ 85.16 [1] 79.99 [1] 93.78 [2] 82.59 [2] 82.06 [3] 81.60 [4] 76.50 [5] 71.89 [6] 70.10 [7] 74.30 [8]
2Increase2.svg 1 Sinopharm Flag of the People's Republic of China.svg  CHN SEHK :  1099 80.19 [9] 75.68 [9] 71.75 [10] 60.18 [11] 48.75 [12] 43.63 [13] 36.56 [14] 32.36 [15] 28.32 [16]
3Increase2.svg 1 Roche Flag of Switzerland (Pantone).svg  SUI SIX :  ROG 68.48 [17] 69.77 [18] 67.83 [19] 62.99 [19] 63.85 [20] 56.86 [21] 57.37 [22] 50.11 [23] 47.70 [24] 49.86 [25]
4Increase2.svg 1 Merck & Co. Flag of the United States.svg  USA NYSE :  MRK 60.12 [26] 59.28 [27] 48.70 [28] 41.52 [28] 46.84 [29] 42.30 [30] 40.10 [31] 39.80 [32] 39.50 [33] 42.24 [34]
5Decrease2.svg 4 Pfizer Flag of the United States.svg  USA NYSE :  PFE 58.50 [35] 100.33 [36] 81.29 [37] 41.91 [38] 41.17 [38] 40.83 [38] 52.54 [39] 52.82 [40] 48.85 [41] 49.61 [42]
6Steady2.svg AbbVie Flag of the United States.svg  USA NYSE :  ABBV 54.32 [43] 58.05 [44] 56.20 [45] 45.80 [45] 33.27 [46] 32.75 [47] 28.22 [48] 25.56 [49] 22.82 [50]
7Steady2.svg Bayer Flag of Germany.svg  GER FWB :  BAYN 51.72 [51] 53.88 [52] 49.46 [53] 47.40 [54] 48.02 [55] 45.06 [56] 37.94 [57] 25.27 [58] 24.09 [59] 25.47 [60]
8Increase2.svg 1 Sanofi Flag of France.svg  FRA NYSE :  SNY 46.84 [61] 46.86 [62] 43.24 [63] 41.27 [64] 39.28 [65] 39.07 [66] 42.91 [67] 36.57 [68] 36.73 [69] 43.07 [70]
9Increase2.svg 2 AstraZeneca Flag of the United Kingdom.svg  GBR
Flag of Sweden.svg  SWE 		LSE :  AZN 45.81 [71] 44.35 [72] 37.42 [73] 26.62 [74] 24.38 [75] 22.09 [76] 22.47 [77] 23.00 [78] 24.71 [79] 26.10 [80]
10Decrease2.svg 2 Novartis Flag of Switzerland (Pantone).svg  SUI NYSE :  NVS 45.44 [81] 50.55 [82] 51.63 [83] 48.66 [83] 47.45 [84] 44.75 [85] 49.11 [86] 48.52 [87] 49.41 [88] 58.00 [89]
11Decrease2.svg 1 Bristol Myers Squibb Flag of the United States.svg  USA Nasdaq :  BMY 45.01 [90] 46.16 [91] 46.39 [92] 42.52 [92] 26.15 [93] 22.56 [94] 20.80 [95] 19.43 [96] 16.56 [97] 15.88 [98]
12Steady2.svg Abbott Laboratories Flag of the United States.svg  USA Nasdaq :  ABT 40.11 [99] 43.65 [100] 43.08 [101] 34.61 [102] 31.90 [103] 30.60 [104] 27.39 [105] 20.85 [106] 20.41 [107] 20.25 [108]
13Steady2.svg GlaxoSmithKline Flag of the United Kingdom.svg  GBR LSE :  GSK 38.63 [109] 36.14 [110] 46.91 [111] 46.17 [112] 43.92 [113] 43.14 [114] 42.05 [115] 34.79 [116] 29.84 [117] 37.96 [118]
14Increase2.svg 2 Eli Lilly & Co Flag of the United States.svg  USA NYSE :  LLY 34.12 [119] 28.54 [120] 28.32 [121] 24.54 [122] 22.32 [123] 21.49 [124] 22.90 [125] 21.22 [126] 20.00 [127] 19.62 [128]
15Increase2.svg 5 Novo Nordisk Flag of Denmark.svg  DEN NYSE :  NVO 33.83 [129] 25.46 [130] 21.66 [131] 19.52 [131] 18.30 [132] 6.99 [133] 18.77 [134] 16.61 [135] 16.06 [136] 15.83 [137]
16Decrease2.svg 2 Shanghai Pharmaceuticals Flag of the People's Republic of China.svg  CHN SSE : 601607 32.33 [138] 31.82 [139] 29.29 [139] 27.50 [139] 23.45 [139] 19.28 [139] 17.80 [140] 15.55 [140] 13.62 [140]
17Decrease2.svg 2 Takeda Pharmaceutical Flag of Japan.svg  JPN TYO : 4502 30.34 [141] 29.31 [142] 27.76 [143] 31.17 [144] 19.10 [145] 16.70 [146] 15.96 [147] 14.9316.84
18Steady2.svg Amgen Flag of the United States.svg  USA Nasdaq :  AMGN 28.19 [148] 26.32 [149] 25.98 [150] 25.42 [151] 23.40 [152] 23.70 [153] 22.80 [154] 22.99 [155] 21.66 [156] 20.06 [157]
19Increase2.svg 1 Boehringer Ingelheim Flag of Germany.svg  GER Private27.70 [158] 25.90 [159] 22.50 [160] 22.40 [161] 21.75 [162] 21.67 [163] 17.54 [164] 16.41 [164] 17.70 [164]
20Decrease2.svg 3 Gilead Sciences Flag of the United States.svg  USA Nasdaq :  GILD 27.12 [165] 27.28 [166] 27.31 [166] 24.69 [167] 22.45 [168] 22.13 [169] 25.70 [170] 30.39 [170] 32.15 [170] 24.47 [170]
21Increase2.svg 1 Siemens Healthineers Flag of Germany.svg  GER FWB :  SHL 23.32 [171] 23.09 [172] 20.61 [173] 16.56 [173] 16.62 [174] 15.37 [175] 16.56 [176] 14.25 [176] 14.06 [176]
22Decrease2.svg 1 Merck Group Flag of Germany.svg  GER ETR: MRK 22.79 [177] 23.64 [178] 21.40 [179] 20.08 [180] 18.25 [181] 16.48 [182] 18.70 [183] 16.62 [184] 14.25 [185] 15.29 [186]
23Steady2.svg Jointown Pharmaceutical Flag of the People's Republic of China.svg  CHN SSE : 600998 19.81 [187] 18.04 [188] 16.34 [189] 14.67 [190] 12.85 [191] 10.90 [192] 9.07 [193] 7.31 [194] 6.05 [195]
24Steady2.svg GE Healthcare Flag of the United States.svg  USA Nasdaq :  GEHC 19.55 [196] 18.34 [197] 17.73 [198] 18.01 [199] 19.94 [200] 19.78 [200] 19.02 [200] 18.21 [200] 17.64 [200]
25Increase2.svg 2 Teva Pharmaceuticals Flag of Israel.svg  ISR Nasdaq :  TEVA 15.85 [201] 14.93 [202] 15.88 [203] 16.66 [204] 16.89 [205] 18.90 [206] 22.40 [207] 21.90 [208] 20.00 [209] 20.27 [210]
26Steady2.svg Kenvue Flag of the United States.svg  USA NYSE :  KVUE 15.44 [211] 14.95 [211]
27Decrease2.svg 1 Viatris Flag of the United States.svg  USA Nasdaq :  VTRS 15.43 [212] 16.22 [213] 17.81 [213] 11.95 [214]
28Decrease2.svg 1 Baxter International Flag of the United States.svg  USA NYSE :  BAX 14.81 [215] 15.11 [216] 12.78 [217] 11.63 [218] 11.36 [218] 11.13 [219] 10.56 [219] 10.16 [220] 9.97 [221] 10.72 [222]
29Steady2.svg Haleon Flag of the United Kingdom.svg  GBR LSE :  HLN 14.29 [223] 13.14 [224] 11.77 [225]
30Steady2.svg Otsuka Holdings Flag of Japan.svg  JPN TYO : 4578 13.05 [226] 11.65 [227] 11.06 [227] 10.85 [227] 10.04 [227] 9.64 [227] 9.29 [227] 11.10 [227] 9.52 [227]
31Steady2.svg Regeneron Pharmaceuticals Flag of the United States.svg  USA Nasdaq :  REGN 13.12 [228] 12.17 [229] 16.07 [230] 8.50 [230] 7.86 [231] 6.71 [231] 5.87 [231] 4.86 [232] 4.10 [233] 2.82 [233]
32Steady2.svg Astellas Pharma Flag of Japan.svg  JPN TYO : 4503 10.87 [234] 10.08 [235] 10.85 [236] 11.29 [236] 12.27 [237] 12.0712.6311.4810.49

See also

Related Research Articles

<span class="mw-page-title-main">Pharmaceutical Research and Manufacturers of America</span> Trade group

Pharmaceutical Research and Manufacturers of America, formerly known as the Pharmaceutical Manufacturers Association, is a trade group representing companies in the pharmaceutical industry in the United States. Founded in 1958, PhRMA lobbies on behalf of pharmaceutical companies. PhRMA is headquartered in Washington, DC.

An epinephrine autoinjector is a medical device for injecting a measured dose or doses of epinephrine (adrenaline) by means of autoinjector technology. It is most often used for the treatment of anaphylaxis. The first epinephrine autoinjector was brought to market in 1983.

<span class="mw-page-title-main">Bristol Myers Squibb</span> American pharmaceutical company

The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb (BMS), is an American multinational pharmaceutical company. Headquartered in Princeton, New Jersey, BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion.

Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company is a component of the Euro Stoxx 50 stock market index. In 2023, the company’s seat in Forbes Global 2000 was 89.

<span class="mw-page-title-main">Amgen</span> American multinational biopharmaceutical company

Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. One of the world's largest independent biotechnology companies, Amgen's Thousand Oaks staff in 2022 numbered approximately 5,000 and included hundreds of scientists, making Amgen the largest employer in Ventura County. As of 2022, Amgen has approximately 24,000 staff in total.

<span class="mw-page-title-main">Judy Lewent</span>

Judith Carol Lewent is a business executive who served as chief financial officer of Merck & Co. from 1990 until her retirement from the company in 2007. Since her retirement from Merck, she has continued to serve on multiple corporate boards, including the boards of GlaxoSmithKline, Thermo Fisher Scientific and Motorola Solutions. She also served on the board of Purdue Pharma until her departure from the company in 2014.

<span class="mw-page-title-main">Genome Valley</span> Life Sciences in Telangana, India

Genome Valley is an Indian high-technology business district spread across 2,000-acre (8.1 km2)/(3.1 sq mi) in Hyderabad, India. It is located across the suburbs, Turakapally, Shamirpet, Medchal, Uppal, Patancheru, Jeedimetla, Gachibowli and Keesara. The Genome Valley has developed as a cluster for Biomedical research, training and manufacturing. Genome Valley is now into its Phase III, which is about 11 km from the Phase I and II with the total area approximately 2,000-acre (8.1 km2).

<span class="mw-page-title-main">AIM at Melanoma Foundation</span>

The AIM at Melanoma Foundation(AIM) is a nonprofit organization focused on melanoma research.

The Reagan-Udall Foundation for the Food and Drug Administration is a private nonprofit (501c3) organization, created to support the mission of the U.S. Food and Drug Administration (FDA) to help equip FDA staff with the highest caliber, regulatory science and technology in order to enhance the safety and effectiveness of FDA regulated products. Although it was mandated by Congress in the Food and Drug Administration Amendments Act of 2007 to help support and promote FDA's regulatory science priorities, it is independent of the agency, with its own Board of Directors, staff and research agenda. The Reagan-Udall Foundation creates public–private partnerships to advance research in regulatory science, enhance medical decision making, and promote innovation. It also advances regulatory science through fellowships and other training programs, both for private scientists and for FDA staff.

Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list.

Horizon Therapeutics was a biopharmaceutical company focused on researching, developing, and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. Horizon primarily markets products in the United States, which represented 97% of Horizon's 2019 worldwide sales. Amgen acquired the company in October 2023.

The pharmaceutical industry in Puerto Rico encompasses more than half of all manufacturing done in Puerto Rico. As the island's most prominent industry, pharmaceutics generates more than 18,000 jobs, pays more than US$3 billion in taxes, comprises about half of total exports, and has generated more than 25% of the island's GDP for the past four decades. Comparatively, Puerto Rico is the fifth largest area in the world for pharmaceutical manufacturing with more than 80 plants, including:

<span class="mw-page-title-main">Sanofi–GSK COVID-19 vaccine</span> Vaccine candidate against COVID-19

The Sanofi–GSK COVID-19 vaccine sold under the brand name VidPrevtyn Beta, is a COVID-19 vaccine developed by Sanofi Pasteur and GSK.

<span class="mw-page-title-main">Innovative Medicines Canada</span> Association of pharmaceutical companies

Innovative Medicines Canada (IMC) is a national association of pharmaceutical companies that represents the interests of the research-based pharmaceutical industry in Canada. Its membership includes biopharmaceutical companies, vaccine developers, and manufacturers of medical devices, and works with government agencies, insurance companies, healthcare professionals and other stakeholders in the regulation and promotion of medicines.

<span class="mw-page-title-main">Pharmaceutical Advertising Advisory Board</span> Canadian not-for-profit organization

The Pharmaceutical Advertising Advisory Board (PAAB) is a Canadian not-for-profit organization based in Pickering, Ontario. Acting as a pseudo-regulatory body, PAAB offers review and pre-clearance services recognized by Health Canada to pharmaceutical companies and marketing agencies who wish to advertise directly to consumers and/or healthcare professionals. It is financed on a fee-for-service basis.

BIOTECanada, or the Industrial Biotechnology Association of Canada, is a Canadian biotechnology industry association based in Ottawa, Ontario. It is an industry-funded membership organization composed of over 250 national and international pharmaceutical and gene therapy companies, medical device manufacturers, agricultural science businesses, law firms, academic institutions, research and development networks, advertising agencies, insurance companies and financial services firms.

References

  1. 1 2 "Johnson & Johnson Reports Q4 and Full-Year 2023 Results".
  2. 1 2 Johnson & Johnson Reports Q4 and Full-Year 2021 Results (Report). Johnson & Johnson. 25 January 2022.
  3. ↑ "Johnson & Johnson Reports 2019 Fourth-Quarter And Full Year Results". BioSpace. Retrieved 24 December 2022.
  4. ↑ "Johnson & Johnson Reports 2018 Fourth-Quarter Results". Content Lab - U.S.
  5. ↑ "Johnson & Johnson Reports 2017 Fourth-Quarter Results: - Johnson & Johnson". www.jnj.com.
  6. ↑ "Johnson & Johnson Reports 2016 Fourth-Quarter Results - Johnson & Johnson". www.jnj.com.
  7. ↑ "Johnson & Johnson Reports 2015 Fourth-Quarter Results". Archived from the original on 2016-02-11. Retrieved 2018-01-28.
  8. ↑ "Johnson & Johnson Reports 2014 Fourth-Quarter and Full-Year Results - Johnson & Johnson". www.jnj.com.
  9. 1 2 "Annual Results Announcement for the year ended 31 December 2022" (PDF).
  10. ↑ All For Health Health For All: Annual Report 2020 (PDF) (Report). Sinopharm Group Co. Ltd. 2020.
  11. ↑ "Archived copy" (PDF). Archived from the original (PDF) on 2020-06-27. Retrieved 2020-04-30.{{cite web}}: CS1 maint: archived copy as title (link)
  12. ↑ "Archived copy" (PDF). Archived from the original (PDF) on 2021-02-06. Retrieved 2020-04-30.{{cite web}}: CS1 maint: archived copy as title (link)
  13. ↑ "Archived copy" (PDF). Archived from the original (PDF) on 2021-02-04. Retrieved 2020-04-30.{{cite web}}: CS1 maint: archived copy as title (link)
  14. ↑ "Archived copy" (PDF). Archived from the original (PDF) on 2021-02-04. Retrieved 2020-04-30.{{cite web}}: CS1 maint: archived copy as title (link)
  15. ↑ "Archived copy" (PDF). Archived from the original (PDF) on 2021-02-04. Retrieved 2020-04-30.{{cite web}}: CS1 maint: archived copy as title (link)
  16. ↑ "Archived copy" (PDF). Archived from the original (PDF) on 2021-02-04. Retrieved 2020-04-30.{{cite web}}: CS1 maint: archived copy as title (link)
  17. ↑ "Roche Finance Report 2023" (PDF).
  18. ↑ "Roche Finance Report 2022" (PDF).
  19. 1 2 "[Ad hoc announcement pursuant to Art. 53 LR] Roche reports good results in 2021". Roche.
  20. ↑ "Archived copy" (PDF). Archived from the original (PDF) on 2020-01-31. Retrieved 2020-01-31.{{cite web}}: CS1 maint: archived copy as title (link)
  21. ↑ "Archived copy" (PDF). Archived from the original (PDF) on 2019-02-07. Retrieved 2019-02-06.{{cite web}}: CS1 maint: archived copy as title (link)
  22. ↑ "Roche reports good results in 2017". www.roche.com.
  23. ↑ "Archived copy" (PDF). Archived from the original (PDF) on 2018-01-29. Retrieved 2018-01-28.{{cite web}}: CS1 maint: archived copy as title (link)
  24. ↑ "Archived copy" (PDF). Archived from the original (PDF) on 2017-01-10. Retrieved 2018-01-28.{{cite web}}: CS1 maint: archived copy as title (link)
  25. ↑ "Archived copy" (PDF). Archived from the original (PDF) on 2016-12-03. Retrieved 2018-01-28.{{cite web}}: CS1 maint: archived copy as title (link)
  26. ↑ "Merck Announces Fourth-Quarter and Full-Year 2023 Financial Results" (PDF).
  27. ↑ "Merck Announces Fourth-Quarter and Full-Year 2022 Financial Results".
  28. 1 2 "Merck Announces Fourth-Quarter and Full-Year 2021 Financial Results".
  29. ↑ "Merck Announces Fourth-Quarter and Full-Year 2019 Financial Results".
  30. ↑ "Merck Announces Fourth-Quarter and Full-Year 2018 Financial Results". BioSpace.
  31. ↑ LaVito, Angelica (2 February 2018). "Merck posts mixed fourth-quarter results as Keytruda sales skyrocket". CNBC .
  32. ↑ Merck & Co., Inc US Securities and Exchange Office
  33. ↑ Merck & Co., Inc US Securities and Exchange Office
  34. ↑ Merck & Co., Inc US Securities and Exchange Office
  35. ↑ "Pfizer Reports Full-Year 2023 Results" (PDF).
  36. ↑ "Pfizer Reports Record Full-Year 2022 Results" (PDF).
  37. ↑ Pfizer Reports Fourth-Quarter and Full-Year 2021 Results (PDF) (Report). Pfizer. 2021.
  38. 1 2 3 Annual report Pfizer
  39. ↑ Pfizer Reports Fourth-Quarter and Full-Year 2017 Results Provides 2018 Financial Guidance (PDF) (Report). Pfizer. 30 January 2018.
  40. ↑ Appendix A: 2016 Financial Report (PDF) (Report). Pfizer Inc. and Subsidiary Companies. 2016.
  41. ↑ 2015 Financial Report (PDF) (Report). Pfizer Inc. and Subsidiary Companies. 2015.
  42. ↑ 2014 Financial Report: Appendix A (PDF) (Report). Pfizer Inc. and Subsidiary Companies. 2014.
  43. ↑ "AbbVie Reports Full-Year and Fourth-Quarter 2023 Financial Results".
  44. ↑ "AbbVie Reports Full-Year and Fourth-Quarter 2022 Financial Results".
  45. 1 2 "AbbVie Reports Full-Year and Fourth-Quarter 2021 Financial Results". North Chicago, Ill.: Abbvie. 2 February 2022. Retrieved 2022-09-26.
  46. ↑ "AbbVie Reports Full-Year and Fourth-Quarter 2019 Financial Results".
  47. ↑ "AbbVie Reports Full-Year and Fourth-Quarter 2018 Financial Results - AbbVie News Center". news.abbvie.com.
  48. ↑ "Financial Release - AbbVie". investors.abbvie.com.
  49. ↑ "Financial Release - AbbVie". investors.abbvie.com.
  50. ↑ "Financial Release - AbbVie". investors.abbvie.com.
  51. ↑ "Bayer Annual Report 2023" (PDF).
  52. ↑ "Bayer Annual Report 2022" (PDF).
  53. ↑ Bayer Annual Report 2021 (PDF) (Report). Bayer. 2021.
  54. ↑ "Bayer Annual report 2020" (PDF).
  55. ↑ "Bayer Annual Report 2019" (PDF).
  56. ↑ "Bayer Annual Report 2018". www.annualreport2018.bayer.com.
  57. ↑ "Bayer Annual Report 2017" (PDF).
  58. ↑ "Bayer Annual Report 2016" (PDF).
  59. ↑ "Bayer Annual Report 2015" (PDF).
  60. ↑ "Bayer Annual Report 2014" (PDF).
  61. ↑ "Sanofi Delivers Solid Sales and Business EPS Growth".
  62. ↑ "Sanofi Form 20-F 2022" (PDF).
  63. ↑ "Sanofi Form 20-F 2021" (PDF).
  64. ↑ "Sanofi Form 20-F 2020" (PDF).
  65. ↑ "Sanofi Form 20-F 2019" (PDF).
  66. ↑ "Sanofi Form 20-F 2018" (PDF).
  67. ↑ "Sanofi Form 20-F 2017" (PDF).
  68. ↑ "Sanofi Form 20-F 2016" (PDF).
  69. ↑ "Sanofi Form 20-F 2015" (PDF).
  70. ↑ "Sanofi Form 20-F 2014" (PDF).
  71. ↑ "Full year and Q4 2023 results" (PDF). AstraZeneca.
  72. ↑ "Full year and Q4 2022 results" (PDF). AstraZeneca.
  73. ↑ "Full year and Q4 2021 results" (PDF). AstraZeneca.
  74. ↑ "Full-year 2020 results" (PDF). AstraZeneca.
  75. ↑ "Full-year and Q4 2019 results" (PDF). AstraZeneca.
  76. ↑ "Full-year and Q4 2018 results" (PDF). AstraZeneca.
  77. ↑ "Full-Year 2017 Results" (PDF). AstraZeneca.
  78. ↑ "Archived copy" (PDF). Archived from the original (PDF) on 2018-02-03. Retrieved 2018-02-02.{{cite web}}: CS1 maint: archived copy as title (link)
  79. ↑ "Full-Year and Q4 2015 Results". www.astrazeneca.com.
  80. ↑ "AstraZeneca PLC fourth quarter and full year results 2014". www.astrazeneca.com.
  81. ↑ "Novartis Financial Results Q4 2023" (PDF).
  82. ↑ "Novartis Financial Results Q4 2022" (PDF).
  83. 1 2 Media release 2021 Novartis
  84. ↑ Media release 2019 Novartis
  85. ↑ Media release 2018 Novartis
  86. ↑ "Archived copy" (PDF). Archived from the original (PDF) on 2018-01-29. Retrieved 2018-01-28.{{cite web}}: CS1 maint: archived copy as title (link)
  87. ↑ Media release 2016 Novartis
  88. ↑ Media release 2015 Novartis
  89. ↑ Media release 2014 Novartis
  90. ↑ "Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2023" (PDF).
  91. ↑ "Bristol Myers Squibb Q4 2022 Results" (PDF).
  92. 1 2 "Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2021" (PDF) (Press release). New York, U.S.: Bristol Myers Squibb. 4 February 2022. Retrieved 2022-09-26.
  93. ↑ https://www.biospace.com/article/releases/bristol-myers-squibb-reports-fourth-quarter-and-full-year-financial-results-for-2019/?s=79 [ dead link ]
  94. ↑ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year Financial Results - BMS Newsroom". news.bms.com.
  95. ↑ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year Financial Results". investors.bms.com.
  96. ↑ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2016 Financial Results - BMS Newsroom". news.bms.com.
  97. ↑ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2015 Financial Results - BMS Newsroom". news.bms.com.
  98. ↑ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2014 Financial Results - BMS Newsroom". news.bms.com.
  99. ↑ "Abbott reports fourth-quarter and full-year 2023 results".
  100. ↑ "Abbott reports fourth-quarter and full-year 2022 results".
  101. ↑ "Abbott Reports Strong Fourth-Quarter 2021 Results; Issues 2022 Forecast".
  102. ↑ Abbott 2020 Annual Report (Report). Abbott. 2020.
  103. ↑ "Abbott Reports Fourth-Quarter 2019 Results; Announces Strong Forecast for 2020".
  104. ↑ "Abbott Reports 2018 Results and Issues Strong Forecast for 2019". BioSpace.
  105. ↑ Abbott. "Abbott Reports Fourth-Quarter 2017 Results". www.prnewswire.com.
  106. ↑ Abbott. "Abbott Reports Fourth-Quarter 2016 Results". www.prnewswire.com.
  107. ↑ "Abbott Reports Fourth-Quarter 2015 Results".
  108. ↑ "Abbott Reports Fourth-Quarter 2014 Results".
  109. ↑ "GSK Full-year and Fourth Quarter 2023" (PDF).
  110. ↑ "GSK Full-Year and Fourth Quarter 2022" (PDF).
  111. ↑ "Income statement: Year ended 31 December 2021" (PDF).
  112. ↑ GSK Annual Report 2020 (PDF) (Report). GSK. 2020.
  113. ↑ "Full year and fourth quarter 2019" (PDF) (Press release). London, U.K.: GSK. 5 February 2020. Retrieved 2022-09-26.
  114. ↑ "GSK delivers sales, earnings and cash flow growth in 2018 - GSK". www.gsk.com.
  115. ↑ "Full year and fourth quarter 2017" (PDF) (Press release). London, U.K.: GSK. 7 February 2018. Retrieved 2022-09-26.
  116. ↑ GSK Annual Report 2016 (PDF) (Report). GSK. 2016.
  117. ↑ GSK Annual Report 2015 (PDF) (Report). GSK. 2015.
  118. ↑ GSK Annual Report 2014 (PDF) (Report). GSK. 2014.
  119. ↑ "Lilly Reports Strong Fourth-Quarter 2023 Financial Results".
  120. ↑ "Lilly Reports Fourth-Quarter 2022 Financial Results".
  121. ↑ "Lilly 2021 Business Results". Lilly.
  122. ↑ "Lilly 2020 Business Results". Lilly.
  123. ↑ "Lilly Reports Strong Fourth-Quarter and Full-Year 2019 Financial Results, Updates 2020 Guidance for Pending Dermira Acquisition".
  124. ↑ "Lilly Reports Strong Fourth-Quarter and Full-Year 2018 Financial Results, Lowers 2019 EPS Guidance to Reflect the Pending Acquisition of Loxo Oncology". BioSpace.
  125. ↑ "Archived copy" (PDF). Archived from the original (PDF) on 2018-02-02. Retrieved 2018-02-01.{{cite web}}: CS1 maint: archived copy as title (link)
  126. ↑ "Lilly Reports Fourth-Quarter and Full-Year 2016 Results (NYSE:LLY)". investor.lilly.com.
  127. ↑ "Archived copy" (PDF). Archived from the original (PDF) on 2018-02-02. Retrieved 2018-02-01.{{cite web}}: CS1 maint: archived copy as title (link)
  128. ↑ "Archived copy" (PDF). Archived from the original (PDF) on 2018-02-02. Retrieved 2018-02-01.{{cite web}}: CS1 maint: archived copy as title (link)
  129. ↑ "Novo Nordisk's sales increased by 31% in 2023".
  130. ↑ "Novo Nordisk Financial report for the period 1 January 2022 to 31 December 2022".
  131. 1 2 Novo Nordisk Annual Report 2021 (PDF) (Report). Novo Nordisk. 2021.
  132. ↑ "Archived copy" (PDF). Archived from the original (PDF) on 2020-09-23. Retrieved 2020-02-12.{{cite web}}: CS1 maint: archived copy as title (link)
  133. ↑ "Archived copy" (PDF). Archived from the original (PDF) on 2019-02-22. Retrieved 2019-02-21.{{cite web}}: CS1 maint: archived copy as title (link)
  134. ↑ "News details". www.novonordisk.com. Archived from the original on 2018-02-02. Retrieved 2018-02-01.
  135. ↑ "Archived copy" (PDF). Archived from the original (PDF) on 2017-03-22. Retrieved 2018-02-01.{{cite web}}: CS1 maint: archived copy as title (link)
  136. ↑ Transcripts, SA (3 February 2016). "Novo Nordisk's (NVO) CEO Lars Rebien Sorensen on Q4 2015 Results - Earnings Call Transcript".
  137. ↑ Transcripts, SA (30 January 2015). "Novo Nordisk's (NVO) CEO Lars Sorensen on Q4 2014 Results - Earnings Call Transcript".
  138. ↑ "Shanghai Pharmaceuticals 2022 Annual Results Announcement" (PDF).
  139. 1 2 3 4 5 2021 Annual Results Announcement (PDF) (Report). Shanghai Pharmaceuticals.
  140. 1 2 3 2017 Annual Report (PDF) (Report). Shanghai Pharmaceuticals.
  141. ↑ "Takeda quarterly financial report for the year ended March 31, 2023" (PDF).
  142. ↑ "Takeda quarterly financial report" (PDF). Retrieved June 30, 2022.
  143. ↑ Takeda Quarterly Financial Report (PDF) (Report). Takeda. 31 March 2021.
  144. ↑ "Takeda Accelerates Transformation: Solid FY2019 Results, Confidence in FY2020 Growth Momentum".
  145. ↑ "Takeda Reports FY2018 Full Year Results and Issues FY2019 Guidance".
  146. ↑ "Takeda reports FY2017 full year results and issues FY2018 guidance". www.takeda.com.
  147. ↑ "Takeda Pharmaceutical Company Limited and its Subsidiaries Consolidated Financial Statements Under IFRSs and Independent Auditor's Report" (PDF).
  148. ↑ "Amgen Reports Fourth Quarter and Full Year 2023 Financial Results".
  149. ↑ "Amgen Reports Fourth Quarter and Full Year 2022 Financial Results".
  150. ↑ Amgen Reports Fourth Quarter and Full Year 2021: Financial Results (Report). Amgen. 7 February 2022.
  151. ↑ "2020 Letter to Shareholders". Amgen.
  152. ↑ "Amgen Reports Fourth Quarter and Full Year 2019 Financial Results".
  153. ↑ "Amgen - Investors - Press Release". investors.amgen.com.
  154. ↑ "Amgen Reports Fourth Quarter And Full Year 2017 Financial Results". www.amgen.com.
  155. ↑ Amgen - Investors - Press Release [ dead link ]
  156. ↑ Amgen - Investors - Press Release [ dead link ]
  157. ↑ Amgen - Investors - Press Release [ dead link ]
  158. ↑ "Boehringer Ingelheim Financial Highlights 2023".
  159. ↑ "Boehringer Ingelheim Financial Report 2022" (PDF).
  160. ↑ "Boehringer Ingelheim Summary Report 2021" (PDF).
  161. ↑ "Boehringer Ingelheim Annual Report 2020" (PDF).
  162. ↑ "Boehringer Ingelheim Annual Report 2019" (PDF).
  163. ↑ "Boehringer Ingelheim Annual Report 2018" (PDF).
  164. 1 2 3 "Boehringer Ingelheim Annual Report 2017" (PDF).
  165. ↑ "Gilead Sciences Announces Fourth Quarter and Full Year 2023 Financial Results".
  166. 1 2 "Gilead Sciences Announces Fourth Quarter and Full Year 2022 Financial Results" (PDF).
  167. ↑ "Gilead Sciences Announces Fourth Quarter and Full Year 2020 Financial Results" (PDF).
  168. ↑ "Gilead Sciences Announces Fourth Quarter and Full Year 2019 Financial Results".
  169. ↑ "Gilead Sciences Announces Fourth Quarter and Full Year 2018 Financial Results". BioSpace.
  170. 1 2 3 4 "Investor Overview". Gilead Sciences.
  171. ↑ "Siemens Healthineers closes fiscal year with strong fourth quarter" (PDF).
  172. ↑ "Siemens Healthineers Annual Report 2022" (PDF).
  173. 1 2 Siemens Healthineers Annual Report 2021 (PDF) (Report). Siemens Healthineers. 2021.
  174. ↑ Siemens Healthineers Annual Report 2019 (PDF) (Report). Siemens Healthineers. 2019.
  175. ↑ Siemens Healthineers Annual Report 2018 (PDF) (Report). Siemens Healthineers. 2018.
  176. 1 2 3 Combined Financial Statements for the fiscal years ended September 30, 2017, 2016 and 2015 (PDF) (Report). Siemens Healthineers. 2018.
  177. ↑ "Merck Group Annual Report 2023" (PDF).
  178. ↑ "Merck Group Annual Report 2022" (PDF).
  179. ↑ Merck Annual Report 2021 (PDF) (Report). Merck. 2021.
  180. ↑ Merck Annual Report 2020 (PDF) (Report). Merck. 2020.
  181. ↑ Merck Annual Report 2019 (PDF) (Report). Merck. 2019.
  182. ↑ "Merck Group Annual Report 2018" (PDF).
  183. ↑ "Merck Group Annual Report 2017" (PDF).
  184. ↑ "Merck Group Annual Report 2016" (PDF).
  185. ↑ "Merck Group Annual Report 2015" (PDF).
  186. ↑ "Merck Group Annual Report 2014" (PDF).
  187. ↑ "Google Finance: Jointown Pharmaceutical Group Co Ltd".
  188. ↑ CSR Report 2021 (PDF) (Report). Jointown Pharmaceutical Group.
  189. ↑ CSR Report 2020 (PDF) (Report). Jointown Pharmaceutical Group.
  190. ↑ CSR Report 2019 (PDF) (Report). Jointown Pharmaceutical Group.
  191. ↑ CSR Report 2018 (PDF) (Report). Jointown Pharmaceutical Group.
  192. ↑ CSR Report 2017 (PDF) (Report). Jointown Pharmaceutical Group.
  193. ↑ CSR Report 2016 (PDF) (Report). Jointown Pharmaceutical Group.
  194. ↑ CSR Report 2015 (PDF) (Report). Jointown Pharmaceutical Group.
  195. ↑ CSR Report 2014 (PDF) (Report). Jointown Pharmaceutical Group.
  196. ↑ "GE HealthCare Reports Fourth Quarter and Full Year 2023 Financial Results".
  197. ↑ "GE HealthCare Reports Fourth Quarter and Full Year 2022 Financial Results".
  198. ↑ "GE fourth quarter & full year 2021 performance: Financial results & company highlights" (PDF). GE.
  199. ↑ GE 2020 Annual Report (PDF) (Report). GE. 2020.
  200. 1 2 3 4 5 "General Electric Healthcare segment revenue 2008-2020".
  201. ↑ "Teva Reports Growth in Fourth Quarter and Full Year 2023".
  202. ↑ "Teva Reports Fourth Quarter and Full Year 2022 Financial Results".
  203. ↑ "Teva Reports Fourth Quarter and Full Year 2021 Financial Results" (PDF). Tel Aviv: Teva. 9 February 2022. Retrieved 2022-09-26.
  204. ↑ TEVA
  205. ↑ "Teva Reports Fourth Quarter and Full Year 2019 Financial Results".
  206. ↑ TEVA
  207. ↑ "Teva Reports 2017 Full Year and Fourth Quarter Financial Results". 8 February 2018.
  208. ↑ "Teva Reports Full Year and Fourth Quarter 2016 Financial Results". Archived from the original on 2018-02-03. Retrieved 2018-02-08.
  209. ↑ "Teva Reports Full Year 2015 and Fourth Quarter Financial Results". Archived from the original on 2018-09-15. Retrieved 2018-02-08.
  210. ↑ "Teva Reports Fourth Quarter and Full Year 2014 Results". www.tevapharm.com.
  211. 1 2 "Kenvue Reports Full Year and Fourth Quarter 2023 Results".
  212. ↑ "Viatris Reports Fourth-Quarter and Full-Year 2023 Financial Results".
  213. 1 2 "Viatris Reports Strong Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Financial Guidance".
  214. ↑ "Viatris Reports Strong Fourth Quarter and Full-Year 2021 Financial Results".
  215. ↑ "Baxter Reports Fourth-Quarter and Full-Year 2023 Results".
  216. ↑ "Baxter Reports Fourth-Quarter and Full-Year 2022 Results".
  217. ↑ "Baxter Reports Fourth-Quarter and Full-Year 2021 Results".
  218. 1 2 Statements of Income (Unaudited) Baxter International
  219. 1 2 Statements of Income (Unaudited) Baxter International
  220. ↑ Statements of Income (Unaudited) Baxter International
  221. ↑ Statements of Income (Unaudited) Baxter International
  222. ↑ Statements of Income (Unaudited) Baxter International
  223. ↑ "Haleon 2023 Full Year Results" (PDF).
  224. ↑ "Haleon 2022 Full Year Results" (PDF).
  225. ↑ "Haleon Prospetus" (PDF).
  226. ↑ "Consolidated Financial Results for the Fiscal Year Ended December 31, 2022" (PDF). Otsuka Holdings.
  227. 1 2 3 4 5 6 7 8 "Otsuka Integrated Report 2021" (PDF).
  228. ↑ "Regeneron Reports Fourth Quarter and Full Year 2023 Financial and Operating Results".
  229. ↑ "Regeneron Reports Fourth Quarter and Full Year 2022 Financial and Operating Results".
  230. 1 2 Regeneron Reports Fourth Quarter and Full Year 2021 Financial and Operating Results (Report). Regeneron. 4 February 2022.
  231. 1 2 3 "Regeneron Form 10-K 2019".
  232. ↑ "Regeneron Form 10-K 2016".
  233. 1 2 "Regeneron Form 10-K 2015".
  234. ↑ "Financial Results of Astellas for Fiscal Year 2022" (PDF).
  235. ↑ "Financial Results of Astellas for Fiscal Year 2021" (PDF).
  236. 1 2 For the Year Ended March 31, 2021 Annual Report 2021 (PDF) (Report). Astellas. 31 March 2020.
  237. ↑ "Astellas Pharma Inc. Annual Report 2018" (PDF). www.astellas.com.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.